Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Anika Therapeutics, Inc. · Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

150 daysmedian FDA review time
294 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K250997Integrity™ ImplantAnika Therapeutics, Inc.2025-06-17770
K231968Tactoset® Injectable Bone SubstituteAnika Therapeutics, Inc.2023-12-201700
K223538Integrity ImplantAnika Therapeutics, Inc.2023-08-172670
K223860Integrity™ Bone Staple Fixation SystemAnika Therapeutics, Inc.2023-05-221500
K222487Anika Tissue Tack Fixation SystemAnika Therapeutics, Inc.2023-05-082640
K223915TactosetAnika Therapeutics, Inc.2023-03-29900
K212083Tactoset Injectable Bone SubstituteAnika Therapeutics, Inc.2021-08-31600
K190956SCS 17-01Anika Therapeutics, Inc.2020-01-302940
K173008SCS 17-01Anika Therapeutics, Inc.2017-12-26900

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda